NCT04975503

Brief Summary

Cardiovascular disease continues to be the leading cause of death among women in the Middle East, including Jordan. Sex-specific data focused on cardiovascular disease have been increasing steadily, yet is not the subgroup of young women. This study focuses on classical and novel risk factors of cardiovascular disease in young women compared with older women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
627

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 23, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

August 22, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
Last Updated

January 30, 2024

Status Verified

January 1, 2024

Enrollment Period

2.2 years

First QC Date

July 14, 2021

Last Update Submit

January 29, 2024

Conditions

Keywords

Atherosclerotic cardiovascular diseaseRisk factors

Outcome Measures

Primary Outcomes (1)

  • Prevalence of classical CVD risk factors

    To study the prevalence of the 4 classical risk factors (HTN, DM, smoking, and dyslipidemia) in young women (younger than 50 years of age) who have documented CVD in ambulatory and in-patient settings and compare the data with women older than 50 y of age with CVD.

    August 2021 to September 2020.

Secondary Outcomes (1)

  • Prevalence of novel/emerging CVD risk factors

    August 2021 to September 2022.

Study Arms (2)

Young Women

Young women, aged 18 to 50 years, with documented atherosclerotic cardiovascular disease

Other: Observing cardiovascular risk factors

Older Women

Older women, aged \>50 years, with documented atherosclerotic cardiovascular disease

Other: Observing cardiovascular risk factors

Interventions

Documenting the presence or absence of CVD risk factors in each participant.

Older WomenYoung Women

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsParticipant eligibility is based on self-representation of gender identity.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The prevalence of the 4 classical risk factors (HTN, DM, smoking, and dyslipidemia) will be studied in young women (younger than 50 years of age, and older than 18 y of age) who have documented CVD in ambulatory and in-patient settings. This data will be compared with those from women older than 50 y of age with CVD.

You may qualify if:

  • Women aged 18 y or more.
  • Documented CVD (CAD stable or ACS, PCI, CABG, CVA/TIA, carotid disease, PAD).

You may not qualify if:

  • Women younger than 18 years of age.
  • No documented CVD.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istishari Hospital

Amman, 11880, Jordan

Location

Related Publications (1)

  • Hammoudeh AJ, Jallad M, Khader Y, Badaineh Y, Tabbalat RA, Zammar H, Al-Makhamreh H, Basha A, AlAtteili L, Abuhalimeh R, Fkheideh T, Ababneh A, Ababneh L, Mahmoud SA, Alhaddad IA. Atherosclerotic Cardiovascular Disease Novel and Traditional Risk Factors in Middle Eastern Young Women. The ANCORS-YW Study. Glob Heart. 2024 Jul 15;19(1):59. doi: 10.5334/gh.1341. eCollection 2024.

MeSH Terms

Conditions

Cardiovascular DiseasesAtherosclerosis

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Reham Nasseddin, MD

    Jordan Collaborating Cardiology Group

    STUDY DIRECTOR
  • Laith N Habahbeh, MD

    Jordan Collaborating Cardiology Group

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Interventional Cardiologist, Department of cardiology, Istishari Hospital, Amman, Jordan

Study Record Dates

First Submitted

July 14, 2021

First Posted

July 23, 2021

Study Start

August 22, 2021

Primary Completion

October 30, 2023

Study Completion

October 31, 2023

Last Updated

January 30, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

The individual participant data will be retained with the PI and not shared. Clinical forms with participant initials, rather than full names, will be shared for analysis.

Locations